Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands.
Leishmania donovani, the agent of human visceral leishmaniasis, is an intracellular parasite that must be recognized and internalized by host macrophages to complete its biological cycle. In a search for possible ligands for macrophage surface receptors, glycoconjugates were obtained from Leishmania promastigotes by aqueous, phenol-aqueous, and alkaline extraction. A fucose-mannose glycoproteic ligand, a lipopeptidephosphoglycan, and a phosphate mannogalactan ligand were purified from promastigotes and analyzed for their chemical contents, with special attention to their glycidic moieties. Sugars that were identified as components of these glycoconjugates were tested for their capacity to inhibit promastigote internalization by BALB/c peritoneal macrophages in vitro. Neutral hexoses showed little inhibitory activity; fucose, charged monosaccharides, and a mannose polymer showed the highest activity. Two of the glycoconjugates (fucose-mannose glycoproteic ligand and phosphate mannogalactan ligand) purified from promastigotes were potent inhibitors of internalization, 75% inhibition being obtained at concentrations of 6 to 10 micrograms/ml. The simultaneous presence of both ligands in low concentrations yielded an increase in inhibitory activity above that found for each ligand alone, indicating that promastigotes may use at least two receptor sites for penetration into macrophages. These ligands are specific inhibitors of L. donovani promastigote phagocytosis, since 10 micrograms of each ligand per ml interfered neither with internalization of yeast cells nor with phagocytosis of Leishmania adleri promastigotes.
Palatnik
C B
CB
Departamento de Parasitologia, Universidade Federal do Rio de Janeiro, Brazil.
Borojevic
R
R
Previato
J O
JO
Mendonça-Previato
L
L
D000818:Animals; D006001:Glycoconjugates / Q000494:pharmacology*; D066298:In Vitro Techniques; D007893:Leishmania donovani / Q000032:analysis / Q000276:immunology*; D008024:Ligands; D008264:Macrophages / Q000469:parasitology* / Q000502:physiology; D051379:Mice; D008970:Molecular Weight; D009005:Monosaccharides / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects*; D011134:Polysaccharides / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000502:physiology
D006001:Glycoconjugates; D008024:Ligands; D009005:Monosaccharides; D011134:Polysaccharides; D011956:Receptors, Cell Surface